Majority of HCPs Anxious About Patients’ Long-Term Care During COVID-19
More than half of those surveyed don’t think their patients have access to telemedicine
CONSHOHOCKEN, Pa. – Healthcare practitioners (HCPs) are not only worried about how they will get through COVID-19, but they’re also concerned about the long-term well-being of their patients. A new survey published today by Fingerpaint, a full-service health and wellness marketing agency, shows that the top concern regarding the pandemic for a majority of HCPs revolves around their patients having access to care—and those concerns are not expected to change for months.
The Fingerpaint COVID-19 HCP Survey showed that 59% percent of HCPs were worried about their patients not being diagnosed in a timely manner, and 58% believe their patients will not be able to obtain previously prescribed in-office/outpatient care. More than half of those surveyed (53%) don’t think their patients have the ability to utilize telemedicine and will not be able to refill their medications.
They believe the pandemic will have a long-term impact on their practice. In fact, 59% of them believe they won’t feel more hopeful about the current COVID-19 situation for at least 2 to 6 months.
“As brands refine their marketing efforts, it is important to have a deep understanding of what’s keeping HCPs awake at night and how this pandemic is impacting them and their patients,” said Michelle Petroff, head of Fingerpaint’s Conshohocken office. “Many of the HCPs reached in this survey are not just worried about the short-term issues, but are looking for long-term solutions.”
There was positive news in the survey. While overall 66% of HCPs reported feeling anxious about COVID-19 as it applies to their practice, only 5% went as far as saying that they feel defeated.
The survey link was sent in an email to about 16,000 contacts. Respondents were screened to ensure their status as healthcare professionals who reside in the United States, were board-certified in their specialty, and had a minimum of 4 and maximum of 40 years’ practice experience. A total of 116 healthcare professionals completed the online survey during the week of March 29th, 2020.
Reset your expectations of a health and wellness agency. Fingerpaint is independent by design, with integrated talent across five offices in New York, Pennsylvania, Arizona, New Jersey, and California. Built on a foundation of empathy, Fingerpaint is at its core committed to creating and executing meaningful brand experiences that are never paint by number for healthcare providers, care partners, and patients.
In 2020, Fingerpaint acquired 1798, a market access and commercialization firm in La Jolla, California, adding to its portfolio of services in support of biopharma customers. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine’s list of the 5,000 Fastest-Growing Companies for the past seven years. Founder Ed Mitzen was honored as 2016’s Industry Person of the Year by Med Ad News. Visit us at fingerpaint.com and follow us on Facebook, Twitter, LinkedIn, and Instagram.